Search - tctmd.com

Displaying 381 - 400 of 587

Sort: Relevancy | Date

Presentation TCT 2017

HARMONEE: A Randomized Trial of a Bioabsorbable Polymer-Based DES With a Luminal CD34+ Antibody Coating vs a Durable Polymer-Based DES in Patients With Coronary Artery Disease

Presenter: Fernando Alfonso, Mitchell W. Krucoff

October 30, 2017

Presentation TCT 2017

HREVS: A Randomized Trial of PCI vs CABG vs Hybrid Revascularization in Patients With Coronary Artery Disease

Presenter: Fernando Alfonso, Roman Tarasov

October 30, 2017

Presentation TCT 2017

EXCEL QOL: Quality of Life After PCI vs CABG in Left Main Coronary Artery Disease

Presenter: Gregg W. Stone, Suzanne J. Baron

October 30, 2017

News Conference News TCT 2017

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Michael O'Riordan

October 30, 2017

News Conference News TCT 2017

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Todd Neale

October 30, 2017

Presentation TCT 2017

Slovakia Presents: Case Conclusion - How I Treated This Case

Presenter: Petr Kala, Jochen Wöhrle, Petra Poliacikova

October 30, 2017

Presentation TCT 2017

Germany Comments: How Would I Treat This Case and Why?

Presenter: Petr Kala, Jochen Wöhrle, Thomas Walther

October 30, 2017

Presentation TCT 2017

Slovakia Presents: Case Introduction - A Patient With Critical Coronary Disease and Severe Aortic Stenosis

Presenter: Petr Kala, Jochen Wöhrle, Petra Poliacikova

October 30, 2017

Presentation TCT 2017

Poland Presents: Case Conclusion - How I Treated This Case

Presenter: Petr Kala, Jochen Wöhrle, Dariusz Dudek

October 30, 2017

Presentation TCT 2017

Czech Republic Comments: How Would I Treat This Case and Why?

Presenter: Petr Kala, Jochen Wöhrle, Marian Branny

October 30, 2017

Presentation TCT 2017

Poland Presents: Case Introduction - A Patient With Critical Coronary Disease and Severe Aortic Stenosis

Presenter: Petr Kala, Jochen Wöhrle, Dariusz Dudek

October 30, 2017

Presentation TCT 2017

Slovakia Presents: Current Knowledge Impact of Coronary Artery Disease on TAVR Management and Outcomes

Presenter: Petr Kala, Jochen Wöhrle, Martin Hudec

October 30, 2017

Presentation TCT 2017

Noninvasive Detection of Coronary Artery Disease Using Resting Phase Signals and Advanced Machine Learning

Presenter: Bernard De Bruyne, Evelyn S. Regar, Thomas D. Stuckey

October 30, 2017

Presentation TCT 2017

Coronary Artery Disease: Pathology and Pathogenesis

Presenter: Grzegorz L. Kaluza, Jose M. Wiley

October 29, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Conference News TCT 2016

TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES

Michael O'Riordan

November 02, 2016

Presentation TCT 2016

TCT 517: Fractional Flow Reserve Assessment of Coronary Artery Disease in Patients Undergoing TAVI.

Presenter: Alan C. Yeung, Tim P. van de Hoef

November 01, 2016

Presentation TCT 2016

Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic AF Patient Who Requires PCI

Presenter: David P. Faxon, C. Michael Gibson, Deepak L. Bhatt

November 01, 2016

Presentation TCT 2016

When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy?

Presenter: David P. Faxon, C. Michael Gibson, Roxana Mehran

November 01, 2016

Presentation TCT 2016

Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding

Presenter: David P. Faxon, C. Michael Gibson

November 01, 2016

Advertisement

HARMONEE: A Randomized Trial of a Bioabsorbable Polymer-Based DES With a Luminal CD34+ Antibody Coating vs a Durable Polymer-Based DES in Patients With Coronary Artery Disease

HREVS: A Randomized Trial of PCI vs CABG vs Hybrid Revascularization in Patients With Coronary Artery Disease

EXCEL QOL: Quality of Life After PCI vs CABG in Left Main Coronary Artery Disease

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Slovakia Presents: Case Conclusion - How I Treated This Case

Germany Comments: How Would I Treat This Case and Why?

Slovakia Presents: Case Introduction - A Patient With Critical Coronary Disease and Severe Aortic Stenosis

Poland Presents: Case Conclusion - How I Treated This Case

Czech Republic Comments: How Would I Treat This Case and Why?

Poland Presents: Case Introduction - A Patient With Critical Coronary Disease and Severe Aortic Stenosis

Slovakia Presents: Current Knowledge Impact of Coronary Artery Disease on TAVR Management and Outcomes

Noninvasive Detection of Coronary Artery Disease Using Resting Phase Signals and Advanced Machine Learning

Coronary Artery Disease: Pathology and Pathogenesis

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES

TCT 517: Fractional Flow Reserve Assessment of Coronary Artery Disease in Patients Undergoing TAVI.

Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic AF Patient Who Requires PCI

When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy?

Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content